Claims
- 1. 9-(2-propionyloxyethoxymethyl)guanine.
- 2. A pharmaceutically acceptable salt of 9-(2-propionyloxythoxymethyl)guanine.
- 3. 9-[2(2,2-Dimethylpropionyloxy)ethoxymethyl]guanine or a pharmaceutically acceptable salt thereof.
- 4. The method of treating a susceptible viral infection in a mammal having said viral infection which comprises the administration of an effective antiviral nontoxic amount of 9-(2-propionyloxyethoxymethyl)guanine or a pharmaceutically acceptable salt thereof.
- 5. A pharmaceutical composition comprising an effective antiviral amount of 9-(2-propionyloxyethoxymethyl)guanine or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier therefore.
- 6. The method of treating a susceptible viral infection in a mammal having said viral infection which comprises the administration of an effective antiviral nontoxic amount of 9-[2-(2-Dimethylpropionyloxyethoxymethyl]guanine or a pharmaceutically acceptable salt thereof.
- 7. A pharmaceutical composition comprising an effective antiviral amount of 9-[2-(2,2-Dimethylpropionyloxyethoxymethyl]guanine or a pharmaceutically acceptable salt thereof together with a pharamaceutically acceptable carrier therefore.
- 8. The method according to claim 4 in which the treated viral infection is caused by a herpes virus.
- 9. The method according to claim 6 in which the treated viral infection is caused by a herpes virus.
- 10. 9-(2-acetyloxyethoxymethyl) guanine.
- 11. A pharmacuetically acceptable salt of 9-(2-acetyloxyethoxymethyl) guanine.
- 12. A pharmacuetical composition comprising an effective antiviral amount of 9-(2-acetyloxyethoxymethyl) guanine or a pharmacuetically acceptable salt thereof together with a pharmacuetically acceptable carrier therefore.
- 13. The method of treating a susceptable viral infection in a mammal having said viral infection which comprises the administration of an effective antiviral non toxic amount of 9-(2-acetyloxyethoxymethyl) guanine or a pharmacuetically acceptable salt thereof.
- 14. The method of claim 13 in which the viral infection is a herpes virus infection.
Priority Claims (1)
Number |
Date |
Country |
Kind |
38278/74 |
Sep 1974 |
GBX |
|
Parent Case Info
This is a division, of application Ser. No. 718,105 filed Aug. 27, 1976, now abandoned, which is a continuation in part of U.S. Applications Ser. No. 662,900 filed Mar. 1, 1976, Pat. No. 4,199,57 and Ser. No. 608,263 filed Aug. 27, 1975, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4146715 |
Schaeffer |
Mar 1979 |
|
4199574 |
Schaeffer |
Apr 1980 |
|
Related Publications (1)
|
Number |
Date |
Country |
|
608263 |
Aug 1975 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
718105 |
Aug 1976 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
662900 |
Mar 1976 |
|